soileauifyyfa1786.blogspot.com
Genzyme (NASDAQ: GENZ) found a virus strain and stopped production of two drugs atthe Allston, Mass., facility. The Vesivirus 2117, apparently does not cause human infectiojn but interrupts the growth of cells that are used to make Aldurazyme — a treatment for MPS I, a rare and fatal diseased caused by an enzyme deficiencuy — was last filledr at the Genzyme facility in September according to BioMarin BMRN). The company has about 10 monthws of vialed inventoryon hand, it said, and uses a seconrd fill finish supplier. A third supplier is expected to be qualifiedx laterthis year, BioMarim said. BioMarin makes the bulk material used in Aldurazymd at itsNovato facility.
The Food and Drug Administratio hadinspected Genzyme’s plant in Septembe r and October and reportedlgy was concerned about control s to protect against
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment